Home › Hypoparathyroidism › Nevada
Hypoparathyroidism clinical trials in Nevada
3 studies for Hypoparathyroidism are looking for participants at sites in Nevada.
Cities in Nevada
A Study to Investigate Canvuparatide Compared With Placebo in Adult Patients With Hypoparathyroidism
- MBX Biosciences Investigational Site, Las Vegas
- MBX Biosciences Investigational Site, Reno
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 24, 2026 · NCT07699471Efficacy, Safety, and Tolerability of Encaleret in Participants With Chronic Hypoparathyroidism
- Calcilytix Therapeutics, Inc., a BridgeBio Company, Investigational Site, Reno
RecruitingPhase 3
Ages 16 and older · All sexes · Updated Sep 16, 2026 · NCT07805356A Phase 3 Randomized Clinical Trial to Investigate the Safety and Efficacy of Palopegteriparatide at Doses Greater Than 30 μg/Day in Adult Participants With Hypoparathyroidism
- Ascendis Pharma Investigational Site, Reno
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Aug 24, 2026 · NCT07081997From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.